{
    "clinical_study": {
        "@rank": "87198", 
        "arm_group": [
            {
                "arm_group_label": "Idiopathic Pulmonary Fibrosis", 
                "description": "Questionnaire evaluation"
            }, 
            {
                "arm_group_label": "Non Idiopathic Pulmonary Fibrosis", 
                "description": "Questionnaire evaluation"
            }, 
            {
                "arm_group_label": "Sarciodosis", 
                "description": "Questionnaire evaluation"
            }, 
            {
                "arm_group_label": "Healthy Controls", 
                "description": "Questionnaire evaluation"
            }
        ], 
        "brief_summary": {
            "textblock": "1. To evaluate the health status of patients with Interstitial Lung Disease (ILD), and how\n           this varies between subgroups of ILD.\n\n        2. To investigate the prevalence of symptoms, anxiety, depression, and sleep-disordered\n           breathing within ILD patient population.\n\n        3. To assess the economic impact of ILD.\n\n        4. To understand how self-aware ILD patients are regarding their treatment/management.\n\n        5. To compare the demographic details, including smoking status and occupational history,\n           of patients with interstitial lung disease"
        }, 
        "brief_title": "Interstitial Lung Disease Questionnaire", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Interstitial Lung Disease", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Lung Diseases, Interstitial"
            ]
        }, 
        "detailed_description": {
            "textblock": "Primary endpoint\n\n      \u2022 Health status in the target populations, as determined by the K-BILD questionnaire.\n\n      Secondary endpoints -\n\n        -  Severity of dyspnoea suffered by patients\n\n        -  Prevalence of anxiety and depression\n\n        -  Prevalence of sleep-disordered breathing symptoms\n\n        -  Degree of self-awareness displayed by patients\n\n        -  The costs associated with ILD from a patient and healthcare perspective.\n\n        -  Demographic details"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female\n\n          -  Age greater than 18 years of age\n\n          -  Any smoking status\n\n          -  Diagnosis of Interstitial Lung Disease as defined below\n\n          -  Full pulmonary lung function tests and routine immunological tests undertaken within\n             6 months of entry into study\n\n        Exclusion Criteria:\n\n        \u2022 Unable to give consent to take part"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Secondary Care"
            }
        }, 
        "enrollment": {
            "#text": "304", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 9, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01711151", 
            "org_study_id": "2012RESP05", 
            "secondary_id": "UEAILDQUEST"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "ILD", 
        "lastchanged_date": "October 17, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Norwich", 
                    "country": "United Kingdom", 
                    "state": "Norfolk", 
                    "zip": "NR47UY"
                }, 
                "name": "Norfolk and Norwich Univeristy Hospital NHS foundation Trust"
            }, 
            "investigator": {
                "last_name": "Christopher Atkins", 
                "role": "Sub-Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_groups": "4", 
        "official_title": "Questionnaire Study for Patients With Interstitial Lung Disease", 
        "overall_contact": {
            "email": "a.m.wilson@uea.ac.uk", 
            "last_name": "Andrew M Wilson, MRCP, MD", 
            "phone": "00441603591257"
        }, 
        "overall_contact_backup": {
            "email": "christopher.atkins@nnuh.nhs.uk", 
            "last_name": "Christopher Atkins, MBBS, MRCP", 
            "phone": "00441603286286"
        }, 
        "overall_official": {
            "affiliation": "University of East Anglia", 
            "last_name": "Andrew M Wilson", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "HRQL", 
            "measure": "Difference in the Mean K-BILD score between the 4 groups", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01711151"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Severity of dyspnoea suffered by patients", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "Prevalence of anxiety and depression", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "Prevalence of sleep-disordered breathing symptoms", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "Degree of self-awareness displayed by patients", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "The costs associated with ILD from a patient and healthcare perspective", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "Demographic details", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }
        ], 
        "source": "University of East Anglia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of East Anglia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2012"
    }
}